Source: Abstracts. Conference titles: World Congress of Nephrology. Unidade: ICB
Assunto: IMUNOLOGIA
ABNT
SEMEDO, P. et al. Mesenchymal stem cell therapy in remnant kidney fibrotic model does not improve long term renal outcome. 2007, Anais.. Rio de Janeiro: Sociedade Brasileira de Nefrologia, 2007. . Acesso em: 25 set. 2024.APA
Semedo, P., Cenedeze, A. A., Wang, P. M., Teixeira, V. P. A., Reis, M. A., Pacheco-Silva, A., & Câmara, N. O. S. (2007). Mesenchymal stem cell therapy in remnant kidney fibrotic model does not improve long term renal outcome. In Abstracts. Rio de Janeiro: Sociedade Brasileira de Nefrologia.NLM
Semedo P, Cenedeze AA, Wang PM, Teixeira VPA, Reis MA, Pacheco-Silva A, Câmara NOS. Mesenchymal stem cell therapy in remnant kidney fibrotic model does not improve long term renal outcome. Abstracts. 2007 ;[citado 2024 set. 25 ]Vancouver
Semedo P, Cenedeze AA, Wang PM, Teixeira VPA, Reis MA, Pacheco-Silva A, Câmara NOS. Mesenchymal stem cell therapy in remnant kidney fibrotic model does not improve long term renal outcome. Abstracts. 2007 ;[citado 2024 set. 25 ]